FdaApplication
NDA 021025
Identifiers
- fda_app_no: NDA021025
Properties
| Property | Value |
|---|---|
| applicant_name | NOVARTIS PHARMACEUTICALS CORP |
| application_type | NDA |
| approval_date | 2000-04-21 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EXELON | RIVASTIGMINE TARTRATE | EQ 2MG BASE/ML | SOLUTION;ORAL |
1 product